UTAH OSTEOPOROSIS CENTER -- HIP FRACTURE RISK for WOMEN
Based on
Lunar ProdigyTM Dual Energy X-ray Absorptiometer (DXA) Data
Women -- Four Year Prospective Hip Fracture Risk
![]() |
GREEN: Risk < 1 %
Universal health recommendations *
YELLOW: Risk > 1 %
Treatment needed for significant risks**
RED:
Risk > 4 % Treatment needed (always treat if prior osteoporotic fracture) |
Patient
Name: ______________________________ Date: ______________
Femoral
Neck:
The bone mineral density of _______ gm/cm2 has a T-score of _______.
This represents a ___________% current fracture risk
for age ________.
GREEN Age is an
independent major risk factor for fracture; therefore a low T-score
(e.g., < -2.0) may have
low fracture risk in younger age groups:
* Universal health recommendations:
1200 mg of calcium and Vitamin D 400 IU daily
Regular
exercise
No smoking
and limit alcohol intake (1-2 drinks/d)
YELLOW Some factors may
make fracture more likely than predicted by bone density alone:
** Significant Risk Factors (Strongly consider treatment to
prevent osteoporosis):
Family
history of osteoporotic fracture (especially maternal hip fracture)
Current use
of corticosteroid medication (prednisone or inhaled steroids)
Current
smoking
Body weight
under 120 pounds
RED Treatment indicated: FDA approved treatments
include, for example:
Estrogen, alendronate, risedronate, raloxifene, and
calcitonin.
NOTE: Anyone with a prior osteoporotic fracture requires
pharmacological treatment regardless of bone density measurement.
References:
Greewald, Barajas. 2000. New bone density report form: Improved diagnosis. Arthritis and Rheumatism, 43:S199.
Greenwald, Barajas. 2000. Better bone density reporting: T score report versus fracture report with outcome analysis. J. Bone and Mineral Research. 15:S401.
This form was
modified with permission of Dr. Maria Greenwald.